nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An evaluation of thymidine phosphorylase as a means of preventing thymidine rescue from the thymidylate synthase inhibitor raltitrexed
|
Graham-Cole, Claire L. |
|
2006 |
59 |
2 |
p. 197-206 |
artikel |
2 |
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies
|
Ma, Cynthia |
|
2006 |
59 |
2 |
p. 207-215 |
artikel |
3 |
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma
|
Mita, Monica M. |
|
2006 |
59 |
2 |
p. 165-174 |
artikel |
4 |
A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-α2b in patients with solid tumors
|
Schneider, Bryan |
|
2006 |
59 |
2 |
p. 261-268 |
artikel |
5 |
Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor model
|
Abramjuk, Claudia |
|
2006 |
59 |
2 |
p. 275-282 |
artikel |
6 |
5-Fluorouracil prevents lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells by inhibiting Akt-dependent nuclear factor-κB activation
|
Islam, Shamima |
|
2006 |
59 |
2 |
p. 227-233 |
artikel |
7 |
Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells
|
Müller, Christine |
|
2006 |
59 |
2 |
p. 157-164 |
artikel |
8 |
In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin)
|
Ryu, Jung Su |
|
2006 |
59 |
2 |
p. 283-284 |
artikel |
9 |
Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells
|
Liu, Jingbo |
|
2006 |
59 |
2 |
p. 217-225 |
artikel |
10 |
Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity
|
Henley, D. |
|
2006 |
59 |
2 |
p. 235-249 |
artikel |
11 |
Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting
|
Lu, Hongxia |
|
2006 |
59 |
2 |
p. 175-181 |
artikel |
12 |
Pharmacokinetic and phase II study of heated intraoperative intraperitoneal melphalan
|
Sugarbaker, Paul H. |
|
2006 |
59 |
2 |
p. 151-155 |
artikel |
13 |
Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer
|
Seo, Jae Hong |
|
2006 |
59 |
2 |
p. 269-274 |
artikel |
14 |
Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas
|
Losa, R. |
|
2006 |
59 |
2 |
p. 251-259 |
artikel |
15 |
Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma
|
Carter, Christopher A. |
|
2006 |
59 |
2 |
p. 183-195 |
artikel |